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FIRST CLINICAL CASE REPORTSuccessful interdisciplinary radical treatment of Mycobacterium fortuitum
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GermanyAbstractWe report a case of a 30-year-old woman who experienced recurrent infections of the abdominal wall after travelling to Turkey from
Germany to undergo abdominoplasty for aesthetic reasons. The patient’s Mycobacterium fortuitum infection was successfully treated by
surgery and antibiotic therapy. Surgical tourism— in this case, lipotourism— is resulting in an increasing number of patients in Europe
who may present uncommon disease patterns.
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and both should be considered ﬁrst author.IntroductionIn our daily clinical work we have noted an increasing number
of cosmetic surgeries performed abroad in Eastern and
Southern Europe for ﬁnancial reasons, similar to American
lipotourism, or liposurgery performed abroad, mostly in Latin
America and the Caribbean. In our opinion this cosmetic-
surgery tourism will lead to an increasing number of cases of
rare infections in Europe, as has been observed in the United
States [1–3].
We report a case of a 30-year-old woman, a German of
Turkish origin, who was admitted to our hospital in February
2014 for recurrent infections of the abdominal wall. She re-
ported that she had undergone abdominoplasty for aestheticNew Microbes and New Infections © 2015 The Authors. Published by El
This is an open access artireasons in October 2012. The surgery had been performed in
Turkey for ﬁnancial reasons—the procedure was supposedly
less expensive there. Three months after surgery, in January
2013, she ﬁrst noticed skin lesions near the incision lines. In the
meantime, before she was admitted to our hospital, she had
consulted several physicians regarding various abscesses of the
left abdominal wall, but the abscesses always recurred after a
short period of time.Case reportThe patient was a nonsmoking woman with a normal body mass
index of 21 kg/m2 and without a history of any serious disease
or immunosuppression. Abdominal examination revealed
extensive phlegmon and several locular abscesses in the
abdominal wall (Fig. 1A). The laboratory values revealed mild
anemia and no signs of general infection. We decided to relieve
the largest abscess under local anesthesia, took a swab sample
from an inner wound for microbiologic analysis, initiated anti-
biotic therapy with clarithromycin 500 mg twice a day and
scheduled an extensive surgical debridement of the wounds
with the patient under general anesthesia. Before surgery weNew Microbe and New Infect 2015; 8: 21–23
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FIG. 1. (A) Abdominal wall infection
at ﬁrst outpatient admission. (B)
Abdominal wall reinfection 3 weeks
after surgical debridement. (C)
Abdominal wall after radical debride-
ment. (D) Abdominal wall 5 months
after skin mesh graft transplantation.
22 New Microbes and New Infections, Volume 8 Number C, November 2015 NMNIperformed magnetic resonance tomography (MRT) to exclude
any deeper infections of the abdominal wall and to estimate the
extent of the infection. The MRT revealed no inﬁltrations of the
abdominal muscles; the two largest abscesses measured
9 × 1 cm and 5 × 2 cm.
During the inpatient treatment we performed a surgical
debridement of the wound and initiated a vacuum-assisted
closure (VAC) therapy. In the following 2 weeks we changed
the VAC system twice and achieved secondary wound closure.
The patient was discharged with inconspicuous wounds and in
overall good health.
In the meantime the microbiologic analysis identiﬁed Myco-
bacterium fortuitum. Antimicrobial susceptibility testing by the
gradient diffusion method found the following minimum inhib-
itory concentrations: amikacin 1.0 μg/mL, levoﬂoxacin
0.125 μg/mL, moxiﬂoxacin 0.047 μg/mL, clarithromycin 1.5 μg/
mL, linezolid >256 μg/mL, rifampin >32 μg/mL, tetracycline
0.064 μg/mL, imipenem 4 μg/mL, meropenem 3 μg/mL, ampi-
cillin >256 μg/mL and amoxicillin/clavulanic acid >256 μg/mL.
Histology did not reveal any malignancy of the excised tissue.
Two weeks after discharge the patient again presented with
abdominal wall pain and indurations of the skin (Fig. 1B). We
reinitiated antibiotic therapy with clarithromycin 500 mg twice a
day and reevaluated the surgical and medical treatment optionsNew Microbes and New Infections © 2015 The Authors. Published by Elsevier Ltd on behalf of
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licein close cooperation with the Institute of Medical Microbiology
of the University Hospital Münster. The swab sample taken
from the wound at this time again grew M. fortuitum. Addi-
tionally, multiple ﬂora were identiﬁed, including Prevotella ber-
gensis, Actinomyces europaeus, Staphylococcus epidermidis,
Micrococcus luteus, Lactobacillus sp. and Peptostreptococcus sp.
Because of the continuous progression of the disease over the
last months and the proximity to the internal abdominal organs,
interdisciplinary discussion led to the conclusion that the casewas
a potentially life-threatening illness. It was decided that inpatient
treatment with radical debridement of the infected abdominal
soft tissue, in combination with targeted antimicrobial therapy
according to the results of susceptibility testing, was necessary.
For antimicrobial therapy we decided to treat the patient
intravenously for 14 days with amikacin (15 mg/kg) and moxi-
ﬂoxacin 400 mg once per day, clarithromycin 500 mg twice a
day and ampicillin/sulbactam 3 g every 8 hours.
After that she received oral antimicrobial therapy with
moxiﬂoxacin 400 mg once a day and clarithromycin 500 mg
twice a day for 3 months.
We began the hospital treatment with this extended anti-
biotic therapy and radical debridement (Fig. 1C), initiating VAC
therapy followed by several revisions with continued VAC
therapy to prepare the wound for skin grafting. Three weeksEuropean Society of Clinical Microbiology and Infectious Diseases, NMNI, 8, 21–23
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mesh graft adhered successfully (Fig. 1D).
The patient was discharged from hospital with prescribed
oral antibiotics and was regularly followed up. At the 1-year
follow-up there was no sign of reinfection, and no pathologic
ﬁndings were found in the blood tests.DiscussionM. fortuitum is a rapidly growing mycobacterium that can cause
severe infections leading to unsuccessful wound healing, wound
dehiscence and infection recurrence [4]. Suspicion arises with a
lack of response to conventional antibiotic regimens and if
standard bacterial cultures remain negative. M. fortuitum is
found in lakes, rivers, tap water, wastewater, and dust and dirt,
and it can infect a wound when exposed to contaminated tap
water [5]. Hospital-acquired disease caused by poor hygiene of
sanitary facilities has previously been reported, but these in-
fections usually present as disseminated skin lesions and soft
tissue lesions, predominantly occurring in the setting of severe
immunosuppression, especially in AIDS [6–8].
The involvement of M. fortuitum in surgical site infections is
well documented. It can be the cause of multiple types of in-
fections such as sternal wound infections after cardiothoracic
surgery or after breast augmentation surgery, e.g. due to
contamination of the wound with contaminated tap water
[4,6,7,9]. Recent outbreaks have also been described in
immunocompetent hosts after use of contaminated whirlpool
foot baths in nail salons [10]. M. fortuitum infections after lip-
osurgery have been reported in different continents [11] but to
our knowledge not yet in Europe.
There have been reported outbreaks of Mycobacterium
abscessus wound infections in lipotourists from the United
States who underwent abdominoplasty in the Dominican Re-
public [1]. Travelling to foreign countries, with their supposedly
lower costs for cosmetic surgery, is relatively common in the
United States; these cosmetic surgeries are performed mostly
in Latin America and the Caribbean [1–3,11]. In recent years
this kind of tourism seems to have recruited an increasing
number of patients in Europe too, which may confront physi-
cians with uncommon disease patterns, especially physicians in
private practice and those practicing in general medicine. The
European destinations for such surgical tourism are mostly in
Eastern and Southern Europe. Therefore, it is important to
execute a full history of the patient and to know the signiﬁcant
signs of this rare infection. In particular, a negative standard
bacterial culture, a lack of response to conventional antibiotic
regimens and infection recurrence, particularly months after
surgery, should set physicians’ alarm bells ringing.New Microbes and New Infections © 2015 The Authors. Published by Elsevier Ltd on beha
This is an open access artiWe report a successful surgical and antibiotic treatment of a
M. fortuitum infection after abdominoplasty. In our case neither
surgical treatment nor antibiotic treatment alone was suc-
cessful. We could only achieve cure by close interdisciplinary
collaboration of both medical specialties. Awareness among
physicians will, we hope, result in faster identiﬁcation and
treatment of these cases. It is important to make patients
appreciate the higher standards of hygiene and the more skilled
performance of these procedures even though they are asso-
ciated with higher cost. Bargain hunters should be made aware
that in the end the price of their abdominoplasty may be higher
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